|
Sep 7
|
Abbott Joins Billion Dollar Roundtable
|
|
Sep 6
|
Abbott (ABT) to Advance Diabetes Care With New Acquisition
|
|
Sep 6
|
Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?
|
|
Sep 5
|
Abbott (ABT) Dips More Than Broader Markets: What You Should Know
|
|
Jul 21
|
Abbott Laboratories Has Rallied Towards a Major Breakout Area
|
|
Jul 21
|
Abbott sees recovery in baby formula business post recall
|
|
Jul 21
|
Abbott upgraded, Carvana downgraded: Wall Street's top analyst calls
|
|
Jul 21
|
Abbot upgraded, Carvana downgraded: Wall Street's top analyst calls
|
|
Jul 21
|
Company News for Jul 21, 2023
|
|
Jul 21
|
Q2 2023 Abbott Laboratories Earnings Call
|
|
Jul 20
|
S&P 500 Gains and Losses Today: Stocks Mixed After Latest Earnings Reports
|
|
Jul 20
|
Abbott Flirts With Breakout After Notching A Recovery In Not One, But Two Businesses
|
|
Jul 20
|
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript
|
|
Jul 20
|
Abbott (ABT) Q2 Earnings & Revenues Beat Estimates, Down Y/Y
|
|
Jul 20
|
Midday movers: Netflix, Tesla, IBM, Johnson & Johnson and more
|
|
Jul 20
|
Abbott (ABT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Jul 20
|
Abbott (ABT) Q2 Earnings and Revenues Surpass Estimates
|
|
Jul 20
|
Abbott's strong medical device sales drive upbeat quarter as surgeries rebound
|
|
Jul 20
|
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
|
|
Jul 19
|
20 Countries with Highest Rates of Infant Mortality
|